Japan has the oldest experience in proton therapy outside the United States and Russia. The main treatment indications are hepatoma, lung and oesophageal carcinomas. The last center built in Chiba in the suburbs of Tokyo has two synchrotrons and three treatment rooms. Cost has been close to 2 billion French francs